ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
The Annals of Thoracic Surgery
Volume 85, Issue 5, May 2008, Pages 1740-1746
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (141 K)

  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.athoracsur.2008.01.088    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2008 The Society of Thoracic Surgeons Published by Elsevier Inc.

Original article

The Value of Occult Disease in Resection Margin and Lymph Node After Extrapleural Pneumonectomy for Malignant Mesothelioma

Tommaso Claudio Mineo MDa, Corresponding Author Contact Information, E-mail The Corresponding Author, Vincenzo Ambrogi MDa, Eugenio Pompeo MDa, Alfonso Baldi MDb, Franco Stella MDc, Paolo Aurea MDc and Mario Marino MDa

aDepartment of Thoracic Surgery, Policlinico Tor Vergata University, Rome bAnatomic Pathology Section, Department of Biochemistry and Biophysic “F. Cedrangolo,” Second University of Naples, Naples cGeneral and Thoracic Surgery Department, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy

Accepted 28 January 2008. 
Available online 25 April 2008.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Background

The purpose of this study was to examine the prognostic impact of occult disease after extrapleural pneumonectomy for malignant mesothelioma.

Methods

We reviewed the resection margin and node specimens from 41 consecutive patients undergoing extrapleural pneumonectomy for malignant pleural mesothelioma in different institutions between 1985 and 2004. The specimens were reassessed by immunohistochemical staining with anticalretinin and antimesothelin monoclonal antibodies, and results were used to draw Kaplan–Meier survival curves and perform Cox regression analyses.

Results

Histologic examination showed 34 epithelioid, 4 biphasic, and 3 sarcomatoid subtypes. Results of postoperative TNM staging were that 14 patients were in stage I, 6 were in stage II, and 21 were in stage III. One patient died during the early postoperative period. Median survival was 13 months. Survival was affected by nonepithelial histologic type (p = 0.001), TNM stage (p = 0.007), positive resection margins (p = 0.002), and N disease (p = 0.01). Immunohistochemistry revealed occult positive resection margins in 6 patients, not correlated with T stage. Microscopic N disease was discovered in 5 patients, of whom 2 had their nodes retrieved through cervical mediastinoscopy. No correlation with nodal diameter was found. In all patients microscopic N disease could have been accessible through mediastinoscopy. Overall, the presence of occult disease was diagnosed in 5 new patients and influenced survival more than any other variable, both at univariate (p < 0.001) and multivariate Cox regression analysis (p < 0.0001; odds ratio, 5.4; 95% confidence interval, 3 to 15).

Conclusions

In malignant pleural mesothelioma, the presence of occult disease in resection margins and lymph nodes can be identified by immunohistochemistry and significantly influences the prognosis. Cervical mediastinoscopy is useful in all patients considered for radical resection, but all specimens should be processed with immunohistochemical staining.

10

Article Outline

Patients and Methods
Patients
Surgical Technique
Conventional Pathologic Examination
Adjuvant Therapy
Clinical Follow-Up
Immunohistochemical Studies
Statistical Analysis
Results
Comment
Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.